30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Innovus Pharmaceuticals Inc (INNV)

Track

Stock chart
Ticker: INNV Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
ARMISTICE CAPITAL, LLC
2 purchases — total 23,850 USD
Buy 17 Sep 2019
Value US$4,598,699.56 | Price 426.60 | Shares 25,428
Buy 17 Sep 2019
Value US$3,537,540.83 | Price 326.28 | Shares 31,954
Buy 16 Sep 2019
Value US$4,148,423.43 | Price 231.08 | Shares 10,433
Buy 16 Sep 2019
Value US$3,819,439.87 | Price 34.49 | Shares 41,537
Buy 23 Nov 2017
Value US$488.00 | Price 0.10 | Shares 5,000
Buy 23 Nov 2017
Value US$470.00 | Price 0.09 | Shares 5,000
Buy 23 Nov 2017
Value US$8,334.00 | Price 0.09 | Shares 90,000
Buy 22 Nov 2017
Value US$190.80 | Price 0.10 | Shares 2,000
Buy 22 Nov 2017
Value US$483.03 | Price 0.10 | Shares 4,990
Buy 22 Nov 2017
Value US$473.83 | Price 0.10 | Shares 4,900
Buy 22 Nov 2017
Value US$483.03 | Price 0.10 | Shares 4,990
Buy 12 Jun 2013
Value US$41,793.94 | Price 0.32 | Shares 129,393
Buy 12 Jun 2013
Value US$92,845.70 | Price 0.32 | Shares 287,448
Buy 2 Feb 2013
Value US$118,992.93 | Price 0.48 | Shares 250,406
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-09-18 2019-09-17 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
25,428
426.60
US$4,598,700 		25,428 426.60 US$4,598,700
2019-09-18 2019-09-17 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
31,954 -14.9%
326.28
US$3,537,541 		31,954 -14.9% 326.28 US$3,537,541
2019-09-18 2019-09-16 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
10,433
231.08
US$4,148,423 		10,433 231.08 US$4,148,423
2019-09-18 2019-09-16 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
9,183 +3.3%
2.48
US$22,774 		9,183 +3.3% 2.48 US$22,774
2017-11-27 2017-11-23 B Purchase ESBER HENRY JEMIL
5,000 +5.3%
0.10
US$488 		5,000 +5.3% 0.10 US$488
2017-11-27 2017-11-23 B Purchase ESBER HENRY JEMIL
5,000 +5.6%
0.09
US$470 		5,000 +5.6% 0.09 US$470
2017-11-27 2017-11-23 B Purchase ESBER HENRY JEMIL
90,000 +inf%
0.09
US$8,334 		90,000 +inf% 0.09 US$8,334
2017-11-27 2017-11-22 B Purchase Berholtz Randy

EVP, CORPORATE DEVELOPMENT
2,000 +13.4%
0.10
US$191 		2,000 +13.4% 0.10 US$191
2017-11-27 2017-11-22 B Purchase Berholtz Randy

EVP, CORPORATE DEVELOPMENT
4,990 +50.5%
0.10
US$483 		4,990 +50.5% 0.10 US$483
2017-11-27 2017-11-22 B Purchase Berholtz Randy

EVP, CORPORATE DEVELOPMENT
4,900 +98.2%
0.10
US$474 		4,900 +98.2% 0.10 US$474
2017-11-27 2017-11-22 B Purchase Berholtz Randy

EVP, CORPORATE DEVELOPMENT
4,990 +inf%
0.10
US$483 		4,990 +inf% 0.10 US$483
2013-06-14 2013-06-12 B Purchase Damaj Bassam

President & CEO

Executive Director Large shareholder
129,393 +inf%
0.32
US$41,794 		129,393 +inf% 0.32 US$41,794
2013-06-14 2013-06-12 B Purchase Damaj Bassam

President & CEO

Executive Director Large shareholder
287,448 +6.0%
0.32
US$92,846 		287,448 +6.0% 0.32 US$92,846
2013-02-05 2013-02-02 B Purchase Damaj Bassam

President and CEO

Executive Director Large shareholder
250,406 +inf%
0.48
US$118,993 		250,406 +inf% 0.48 US$118,993
Explore more

More insider trading research around Innovus Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America